Detalles de la búsqueda
1.
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.
Blood
; 121(11): 1968-75, 2013 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23319574
2.
Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.
Blood
; 118(22): 5752-8; quiz 5982, 2011 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21849487
3.
Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma.
Haematologica
; 95(11): 1973-6, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20634494
4.
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.
Haematologica
; 100(2): e56-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25398832
5.
Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial.
Br J Haematol
; 144(3): 367-75, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19036078
6.
Second treatment with rituximab in B-cell non-Hodgkin's lymphoma: efficacy and toxicity on 41 patients treated at CHU-Lyon Sud.
Hematol J
; 5(6): 467-71, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15570286
7.
Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL).
Leuk Lymphoma
; 45(4): 711-4, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15160944
8.
Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
Leuk Lymphoma
; 55(8): 1854-60, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24206091
9.
Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival.
J Clin Oncol
; 30(16): 1949-52, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22547600
10.
Groshong or implanted catheter infections in ambulatory haematological patients.
J Infect Public Health
; 3(3): 134-41, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20869675
11.
Retreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: a single institution case control study.
Leuk Lymphoma
; 51(3): 399-405, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20038227
12.
Best treatment for gastric mucosa-associated lymphoid tissue lymphoma.
Clin Lymphoma
; 4(4): 199-200, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15072609
13.
Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma.
Future Oncol
; 1(3): 297-306, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16556002
14.
Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.
Cancer
; 104(7): 1434-41, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16104036
15.
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Am J Gastroenterol
; 97(2): 292-7, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11866264
16.
Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial.
Blood
; 103(1): 58-66, 2004 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12907440
17.
Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial.
Cancer
; 95(10): 2169-79, 2002 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12412171
Resultados
1 -
17
de 17
1
Próxima >
>>